Bioness, Valencia, California, announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its L300® Foot Drop System to pediatric patients and their caregivers. This is the first FDA-cleared neurostimulation device of this kind for use with children.
In Memoriam: John W. (Bill) Potter, CPO
John W. (Bill) Potter, CPO, passed away in July at the age of 91 in Temple, Texas. Potter worked for...
Read more